Literature DB >> 30615092

Protective Effects of Epigallocatechin-3-Gallate from Green Tea in Various Kidney Diseases.

Rattiyaporn Kanlaya1, Visith Thongboonkerd1.   

Abstract

Kidney diseases are common health problems worldwide. Various etiologies (e.g., diabetes, hypertension, drug-induced nephrotoxicity, infection, cancers) can affect renal function and ultimately lead to development of chronic kidney disease (CKD) and end-stage renal disease (ESRD). The global rise in number of CKD/ESRD patients during recent years has led to tremendous concern to look for effective strategies to prevent or slow progression of CKD and ESRD. Natural compounds derived from herbs or medicinal plants have gained wide attention for scientific scrutiny to achieve such goals. One of such natural compounds that has been extensively investigated is epigallocatechin-3-gallate (EGCG), a major polyphenol found in the tea plant (Camellia sinensis). A growing body of recent evidence has shown that EGCG may be a promising therapeutic or protective agent in various kidney diseases. This article thus highlights recent progress in medical research on beneficial effects of EGCG against a broad spectrum of kidney diseases, including acute kidney injury, cisplatin-induced nephrotoxicity, kidney stone disease, glomerulonephritis, lupus nephritis, renal cell carcinoma, diabetic nephropathy, CKD, and renal fibrosis. The renoprotective mechanisms are also detailed. Finally, future perspectives of medical research on EGCG and its potential use in clinical practice for treatment and prevention of kidney diseases are discussed.

Entities:  

Year:  2019        PMID: 30615092      PMCID: PMC6370267          DOI: 10.1093/advances/nmy077

Source DB:  PubMed          Journal:  Adv Nutr        ISSN: 2161-8313            Impact factor:   8.701


  112 in total

1.  Total phenol, catechin, and caffeine contents of teas commonly consumed in the United kingdom.

Authors:  S Khokhar; S G M Magnusdottir
Journal:  J Agric Food Chem       Date:  2002-01-30       Impact factor: 5.279

Review 2.  Review of renal cell carcinoma and its common subtypes in radiology.

Authors:  Gavin Low; Guan Huang; Winnie Fu; Zaahir Moloo; Safwat Girgis
Journal:  World J Radiol       Date:  2016-05-28

Review 3.  Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals.

Authors:  Shu Wang; Rui Su; Shufang Nie; Ming Sun; Jia Zhang; Dayong Wu; Naima Moustaid-Moussa
Journal:  J Nutr Biochem       Date:  2013-11-05       Impact factor: 6.048

4.  Epigallocatechin-3-gallate activates Nrf2/HO-1 signaling pathway in cisplatin-induced nephrotoxicity in rats.

Authors:  Kazim Sahin; Mehmet Tuzcu; Hasan Gencoglu; Ayhan Dogukan; Mustafa Timurkan; Nurhan Sahin; Abdullah Aslan; Omer Kucuk
Journal:  Life Sci       Date:  2010-07-06       Impact factor: 5.037

Review 5.  Stability of (-)-epigallocatechin gallate and its activity in liquid formulations and delivery systems.

Authors:  Olga Krupkova; Stephen J Ferguson; Karin Wuertz-Kozak
Journal:  J Nutr Biochem       Date:  2016-02-02       Impact factor: 6.048

6.  Evaluation of renal protective effects of the green-tea (EGCG) and red grape resveratrol: role of oxidative stress and inflammatory cytokines.

Authors:  A M El-Mowafy; H A Salem; M M Al-Gayyar; M E El-Mesery; M F El-Azab
Journal:  Nat Prod Res       Date:  2011-04       Impact factor: 2.861

7.  Cellular adaptive response of distal renal tubular cells to high-oxalate environment highlights surface alpha-enolase as the enhancer of calcium oxalate monohydrate crystal adhesion.

Authors:  Rattiyaporn Kanlaya; Kedsarin Fong-Ngern; Visith Thongboonkerd
Journal:  J Proteomics       Date:  2013-01-23       Impact factor: 4.044

8.  Mitochondrial modulation by Epigallocatechin 3-Gallate ameliorates cisplatin induced renal injury through decreasing oxidative/nitrative stress, inflammation and NF-kB in mice.

Authors:  Hao Pan; Jun Chen; Kezhen Shen; Xueping Wang; Ping Wang; Guanghou Fu; Hongzhou Meng; Yimin Wang; Baiye Jin
Journal:  PLoS One       Date:  2015-04-15       Impact factor: 3.240

Review 9.  Clinical use of cabozantinib in the treatment of advanced kidney cancer: efficacy, safety, and patient selection.

Authors:  Steven S Yu; David I Quinn; Tanya B Dorff
Journal:  Onco Targets Ther       Date:  2016-09-23       Impact factor: 4.147

10.  Epigallocatechin-3-gallate Attenuates Renal Damage by Suppressing Oxidative Stress in Diabetic db/db Mice.

Authors:  Xiu Hong Yang; Yu Pan; Xiao Li Zhan; Bao Long Zhang; Li Li Guo; Hui Min Jin
Journal:  Oxid Med Cell Longev       Date:  2016-09-06       Impact factor: 6.543

View more
  10 in total

1.  Troxerutin alleviates kidney injury in rats via PI3K/AKT pathway by enhancing MAP4 expression.

Authors:  Tongxu Guan; Yingce Zheng; Shengzi Jin; Shuang Wang; Mengxin Hu; Xingyao Liu; Siqi Huang; Yun Liu
Journal:  Food Nutr Res       Date:  2022-05-24       Impact factor: 3.221

2.  Tea Ingredients Have Anti-coronavirus Disease 2019 (COVID-19) Targets Based on Bioinformatics Analyses and Pharmacological Effects on LPS-Stimulated Macrophages.

Authors:  Lei Wang; Qing Tao; Zhiguo Wang; Jianfeng Shi; Wei Yan; Li Zhang; Yaoxiang Sun; Xiaoming Yao
Journal:  Front Nutr       Date:  2022-05-20

Review 3.  Natural Plants Compounds as Modulators of Epithelial-to-Mesenchymal Transition.

Authors:  Lorena Avila-Carrasco; Pedro Majano; José Antonio Sánchez-Toméro; Rafael Selgas; Manuel López-Cabrera; Abelardo Aguilera; Guadalupe González Mateo
Journal:  Front Pharmacol       Date:  2019-07-30       Impact factor: 5.810

4.  Epigallocatechin-3-Gallate Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease via Inhibition of Apoptosis and Promotion of Autophagy through the ROS/MAPK Signaling Pathway.

Authors:  Dongdong Wu; Zhengguo Liu; Yizhen Wang; Qianqian Zhang; Jianmei Li; Peiyu Zhong; Zhongwen Xie; Ailing Ji; Yanzhang Li
Journal:  Oxid Med Cell Longev       Date:  2021-04-17       Impact factor: 6.543

Review 5.  Natural products: potential treatments for cisplatin-induced nephrotoxicity.

Authors:  Chun-Yan Fang; Da-Yong Lou; Li-Qin Zhou; Jin-Cheng Wang; Bo Yang; Qiao-Jun He; Jia-Jia Wang; Qin-Jie Weng
Journal:  Acta Pharmacol Sin       Date:  2021-03-09       Impact factor: 7.169

Review 6.  Polyphenols and Their Metabolites in Renal Diseases: An Overview.

Authors:  Íris Guerreiro; Cíntia Ferreira-Pêgo; Diogo Carregosa; Cláudia N Santos; Regina Menezes; Ana S Fernandes; João G Costa
Journal:  Foods       Date:  2022-04-06

Review 7.  Vascular Protective Effect and Its Possible Mechanism of Action on Selected Active Phytocompounds: A Review.

Authors:  Nur Aqilah Kamaruddin; Muhammad Nazrul Hakim Abdullah; Jun Jie Tan; Vuanghao Lim; Lai Yen Fong; Siti Aisyah Abd Ghafar; Yoke Keong Yong
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-16       Impact factor: 2.650

8.  The Effect of Green Tea as an Adjuvant to Enzyme Replacement Therapy on Oxidative Stress in Fabry Disease: A Pilot Study.

Authors:  Giovanni Bertoldi; Gianni Carraro; Verdiana Ravarotto; Valentina Di Vico; Paola Baldini Anastasio; Nicola Vitturi; Francesco Francini; Lucia Federica Stefanelli; Lorenzo A Calò
Journal:  Front Nutr       Date:  2022-07-08

9.  Association between tea intake and hospitalized nephrolithiasis in Chinese adults: A case-control study.

Authors:  Yingyu Liu; Shiyuan Bi; Hexiao Li; Jianxiu Shi; Yang Xia; Kaijun Niu; Song Bai
Journal:  Front Nutr       Date:  2022-09-28

10.  (-)-Epigallocatechin-3-gallate (EGCG) attenuates salt-induced hypertension and renal injury in Dahl salt-sensitive rats.

Authors:  Dan Luo; Jianping Xu; Xuejiao Chen; Xu Zhu; Shuang Liu; Jie Li; Xinting Xu; Xiao Ma; Jinhua Zhao; Xu Ji
Journal:  Sci Rep       Date:  2020-03-16       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.